Friday, 9 September 2016

Bifidobacterium thermophilum RBL67 Inhibits Salmonella enterica Serovar Typhimurium in an In vitro Intestinal Fermentation Model

Infectious gastroenteritis caused by non-typhoidal serovars of Salmonella is usually self-limiting but life-threatening complications may require appropriate antibiotic therapies. Probiotics have evolved as potential alternatives to antibiotics in response to an increasing prevalence of resistant strains, but there are no studies comparing the effectiveness of both treatment strategies on the same intestinal microbiota.

vitro Intestinal Fermentation Model

Infectious gastroenteritis is one of the most common causes of disease in children less than five years old, with rotavirus and food-borne associated non-typhoidal Salmonella predominantly identified as causative agents. Non-typhoidal Salmonella organisms can cause asymptomatic carriage as well as self-limited gastroenteritis. Complications however, include bacteremia and other extra-intestinal manifestations, e.g. osteomyelitis and meningitis, requiring hospitalization and resulting in the risk of serious sequelae and death. Antibiotic treatment is usually not recommended in uncomplicated gastroenteritis because it may prolong the duration of carriage.

In patients at risk of bacteremia however, i.e. young infants, immunocompromised patients, patients with chronic gastrointestinal disease, or patients with malignant diseases, antibiotic treatment is used even though the incidence of treatment failures attributed to antibiotic resistant Salmonella strains is increasing and antibiotics may cause disturbances of the human intestinal ecosystem leading to a disruption of the barrier effect and overgrowth with commensal microorganisms. Alternative treatment strategies combating severe Salmonella infections in children are therefore needed.

No comments:

Post a Comment